# Vitamin D Effect on A Disintegrin-like And Metalloprotease Thrombospondin1 Motif 13& Interleukin 6 in Leukemia

> **NCT05149339** · PHASE1,PHASE2 · COMPLETED · sponsor: **Zagazig University** · enrollment: 38 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Vitamin D Deficiency
- ADAMTS13
- Interleukin 6

## Interventions

- **DRUG:** Cholecalciferol 2800 I.U. ml oral drops

## Key facts

- **NCT ID:** NCT05149339
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2020-02-01
- **Final completion:** 2021-03-15
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2021-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05149339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05149339, "Vitamin D Effect on A Disintegrin-like And Metalloprotease Thrombospondin1 Motif 13& Interleukin 6 in Leukemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05149339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*